Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHartland & Co., LLC
Latest Disclosed Ownership16,782 shares
Latest Disclosed Value $ 2,338,808
Hartland & Co., LLC reports 372.20% increase in ownership of GILD / Gilead Sciences, Inc.

On May 6, 2026 - Hartland & Co., LLC filed a 13F-HR form disclosing ownership of 16,782 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,338,808 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,554 shares of Gilead Sciences, Inc.. This represents a change in shares of 372.20% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F GILEAD SCIENCES COM 375558103 16,782 13,228 372.20 2,339 436.24 0.0214
2026-02-09 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,554 -68 -1.88 436 8.46 0.0055
2025-11-10 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,622 -1,539 -29.82 402 -29.72 0.0053
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 5,161 2,175 72.84 572 71.26 0.0080
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,986 292 10.84 335 34.68 0.0052
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 2,694 -428 -13.71 249 -4.98 0.0038
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 3,122 -85 -2.65 262 18.64 0.0041
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,207 5 0.16 220 1.85 0.0038
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 3,202 -57 -1.75 216 -17.87 0.0107
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 3,259 -20 -0.61 264 7.35 0.0140
2023-11-13 2023-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,279 501 18.03 246 14.49 0.0151
2023-11-07 2023-09-30 13F GILEAD SCIENCES COM 375558103 3,315 537 248 0.0137
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 2,778 -101 -3.51 214 -10.08 0.0130
2023-05-09 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,879 476 19.81 239 15.53 0.0174
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,403 -374 -13.47 206 20.47 0.0162
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 2,777 487 21.27 171 20.42 0.0158
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 2,290 135 6.26 142 10.94 0.0111
2022-05-04 2022-03-31 13F GILEAD SCIENCES COM 375558103 2,155 1,085 101.40 128 64.10 0.0087
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 1,070 -5,576 -83.90 78 -83.19 0.0053
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 6,646 196 3.04 464 4.50 0.0346
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 6,450 131 2.07 444 8.82 0.0342
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 6,319 -406 -6.04 408 4.08 0.0340
2021-02-11 2020-12-31 13F GILEAD SCIENCES COM 375558103 6,725 526 8.49 392 0.00 0.0356
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,199 -312 -4.79 392 -21.76 0.0420
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,511 5,631 639.89 501 659.09 0.0579
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 880 880 66 0.0096
2017-11-09 2017-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,455 -100.00 0 -100.00
2017-08-03 2017-06-30 13F GILEAD SCIENCES COM 375558103 3,455 -965 -21.83 245 -18.33 0.0358
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 4,420 833 23.22 300 16.73 0.0436
2017-02-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 3,587 3,587 257 0.0416
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.